Make Versus Buy: Evaluating your Aseptic Fill/Finish Manufacturing Strategy

By |October 9th, 2019|Drug Product Manufacturing, Useful Tips|

Every biopharma company is eventually faced with the “make versus buy” decision – should they fill/finish their drug product in-house or outsource? Complicating things further, a third option also exists to outsource a portion while retaining some i [...]

New manufacturing strategies for the precision medicine future

By |July 11th, 2019|Drug Product Manufacturing|

Blockbuster drugs and one-size-fits-all treatments now share portfolio space with highly targeted therapies for smaller patient populations. This new era is an opportunity for savvy companies to create greater value, both for patients and themselves. [...]

Selecting the Right CDMO Partner – Three Keys to Success

By |May 16th, 2019|Drug Product Manufacturing|

Outsourcing pharmaceutical manufacturing is becoming essential to remain competitive in the industry. The rise of small-batch personalized medicines and “virtual companies” are key drivers to retain flexible, external manufacturing capabilities. With [...]

Facility of the Future: Our takeaways from the ISPE Aseptic Conference 2019

By |March 27th, 2019|Conference, Drug Product Manufacturing, Manufacturing|

The always-essential 2019 ISPE Aseptic Conference was held in North Bethesda, MD and we were there to assess the trends, check out the leading-edge sessions, and share lessons with industry leaders. Read on to find out what we found interesting or co [...]